Introduction
Infant acute lymphoblastic leukemias and subtypes of acute myeloid leukemias frequently show a cytogenetic aberration at the chromosomal locus 11q23. [1] [2] [3] Similar genetic lesions occur in secondary leukemias after the treatment of neoplastic diseases with topoisomerase II inhibitors. 4, 5 The most common abnormalities in these types of leukemias are reciprocal translocations. More than 40 different 11q23 translocations have been described cytogenetically and at least 17 have been cloned. 6, 7 On a molecular level these events disrupt the MLL gene (also called HRX, ALL-1 or Htrx) and fuse its 5Ј part to one of a large number of heterologous partners. ENL a putative transcription factor encoded at 19p13.1 is one of the more frequent MLL partners. 2 In all sequenced cases the MLL cDNA is fused in-frame to the respective partner resulting in a molecular chimera that can be translated into a full-length fusion protein. The intact MLL gene codes for a large 3968 amino acid protein that shows limited but significant homology to the Drosophila trithorax protein TRX. [8] [9] [10] [11] Trx is a member of the trithorax group (TRX-G) of activator genes that counteract the polycomb group (PC-G) of repressors and it is required to maintain but not to initiate the expression of the Hom-C homeotic genes during Drosophila development. Knockout experiments in mice have shown that MLL plays a similar role in mammals. In these experiments the presence of MLL was crucial for the sustained expression of several Hox genes. [12] [13] [14] Experimental support for the predicted leukemogenic potential of MLL fusion proteins was provided by a study of the MLL-ENL fusion. Retroviral expression of the MLL-ENL polyCorrespondence: RK Slany; Fax: 49 9131 8528526 peptide in mouse bone marrow cells caused colony formation in methylcellulose assays and after re-implantation into syngeneic mice elicited a myeloid type of leukemia. 15, 16 Additional proof for a causative role of the MLL fusion proteins in leukemogenesis came from mouse knock-in studies. A reconstruction of the MLL-AF9 fusion on the chromosomal level caused a myeloid leukemia in the majority of the affected animals. 17 Various functions have been attributed to isolated domains of MLL-ENL either by homology comparison or by experiments assessing the transcriptional properties of partial peptides in artificial fusions with the GAL4 DNA binding domain (GAL4 DNA-BD). Synthetic reporter templates were used in these studies to measure the transcriptional readout and a transcriptional repressor activity was described for the methyltransferase homology region (MT) of MLL. 18, 19 Similarly, a transactivation function could be detected for an engineered fusion between the GAL4 DNA-BD and the ENL Cterminus. 16, 20 Additionally, MLL contains three so-called AThooks, a motif that is used in a great number of proteins as a universal DNA tether that binds to the minor groove of ATrich DNA. 21 No detailed experimental results are available about the overall biological activity of the authentic MLL-ENL fusion protein and it is not known how individual domains with opposite transcriptional properties act in concert on natural promoter templates. Therefore we tested in luciferase reporter assays the influence of MLL-ENL on several original viral and cellular promoters. The murine Hoxa7 gene promoter was included as a highly relevant model system because Hoxa7 was identified as a potential downstream target of unaltered MLL in mouse knockout studies. [12] [13] [14] The expression of Hoxa7 is under control of a well defined and short promoter that directs lacZ expression in transgenic mice in a spatial and temporal pattern identical to that of the endogenous Hoxa7 gene. 22 This promoter is conserved between human and mouse and the human promoter counterpart has been shown to be functional in transgenic mice. 23, 24 We report here that the fusion of MLL and ENL creates a protein with new, unique transcriptional properties that strongly transactivated a variety of promoters. This activation was promoter as well as cell line specific and required the integrity of the MT region of MLL and the C-terminus of ENL. Possible contributions of these domains for the overall activity were analyzed in squelching and gel retardation assays and implications for the process of leukemogenesis by MLL-ENL are discussed.
Materials and methods

DNA manipulation and plasmid construction
All plasmids were generated either by subcloning or by PCR amplification. All PCR products were verified by sequencing to avoid the accidental incorporation of errors by the Taq polymerase. The luciferase reporter plasmids were con-structed as follows: For the Hoxa7 promoter as defined by Pü schel et al 22 a 2.8 kb SacI fragment from the plasmid pm6lacZ4 was subcloned into the luciferase vector pGL-3 basic (Promega, Madison, WI, USA) (plasmid pGL3-Hoxa7). pm6lacZ4 was a gift of Dr P Gruss (Gö ttingen, Germany). The sequence of the murine Hoxa7 region is available under the Genbank accession number U15972. In this sequence the upstream SacI site defines nucleotide number 1. For the promoter studies three constructs with increasing deletions of 5Ј promoter regions were constructed in pGL-3 basic. The construct mut1 contains the promoter sequence from the BamHI site at nt 1185 to the downstream SacI site at nt 2774, mut2 encompasses sequences from nt 1403 to nt 2774 and mut3 from nt 1727 to nt 2774. The CMV promoter and enhancer were excised from the commercial expression plasmid pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) as a Mlul/HindIII fragment and transferred to pGL-3basic. The Herpes simplex thymidine kinase promoter (position −169 to +1) driving a luciferase reporter gene was available as a laboratory stock. The ␣ 2 -macroglobulin minimal promoter (position −48 to +1) construct is described in Ref. 25 . The SV40 promoter without SV40 enhancer sequences was commercially obtained (plasmid pGL-3 promoter, Promega). The retroviral long terminal repeat (LTR) promoter was excised from plasmid pMSCV 26 as a NheI/EcoRI fragment and subcloned into pGL-3 basic.
The construction of the MLL-ENL mutants and the GST-MT expression plasmid has been described previously. 16 Briefly, a MLL-ENL mutant lacking the AT-hook motif was constructed by deleting the amino acids 1 to 613 of the MLL protein. The MT minus mutant lacked the amino acids from position 1037 to 1444 of MLL (position 1444 is at the fusion point with ENL). In the ENL N-terminal deletion mutant the first 426 amino acids out of the total of 555 ENL amino acids that are fused to MLL were deleted. The ENL C-terminal deletion truncated the protein 15 amino acids upstream of the ENL 3Ј end. Finally, a construct that expresses MLL sequences without any fusion partner attached was tested. All MLL-ENL expression constructs were driven by the LTR in the plasmid pMSCV. 26 The GST-MT construct fused the amino acids 1147 to 1241 of MLL with a glutathione-S-transferase moiety.
Cell culture, transfection, and electroporation
Adherent cells were grown in DMEM supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin. Suspension cells were cultured in RPMI1640 + 10% FCS and penicillin/streptomycin. For cultivation of the IL-3-dependent mouse 32D cells 5% to 10% of WEHI-3B (ATCC) conditioned medium was added. All media and supplements were obtained from Life Technologies, Karlsruhe, Germany. The cell lines used were either laboratory stocks, obtained by the American type culture collection (Manassas, VA, USA), or purchased from the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (Gö ttingen, Germany). The HB1119 cell line is described in Ref. 10 . Adherent cells were split before reaching confluency and suspension cell lines were kept at densities below 1 × 10 6 /ml. To avoid senescence new cells were thawed from a common stock every 6 to 8 weeks. For Western blotting the 293 cells were transfected by a standard calcium phosphate precipitate method. Electroporation of the suspension cells was performed according to the DEAE dextran protocol as established by Gauss and Lieber. 27 
Luciferase assays
Luciferase activities were measured with the Luciferase Reporter Assay System (Promega) and a Monolight 2010 luminometer (Analytical Luminescence Laboratories, San Diego, CA, USA) according to instructions of the manufacturers. The protein contents of the extracts was determined with the Bradford method (Bio-Rad protein concentration determination assay, Bio-Rad, Hercules, CA, USA). Luciferase levels within a transfection series were normalized to protein content and the plasmid pGL-3 promoter (Promega) was used as an external control for transfection efficiency and as a standard for comparison between different transfection series.
Western blotting
To verify the integrity of the MLL-ENL constructs the correct expression of the encoded proteins was determined by Western analysis of nuclear extracts of 293 cells transiently transfected with the individual plasmids. Nuclear extracts were produced and Western blotting was performed according to standard procedures. For the detection with the ECL chemoluminescence system (Amersham, UK) the membranes were probed with either a monoclonal anti-MLL antibody or a polyclonal rabbit serum raised against MLL. 28 
Gel mobility shift analysis
For the analysis of the DNA binding properties of the MT region of MLL, bacterially expressed GST-MT fusion protein was purified on glutathione agarose according to the instructions of the manufacturer (Pharmacia, Uppsala, Sweden). For complex formation various amounts of purified protein were incubated with 10 000 c.p.m. (Cerenkov radiation) of 32 P endlabeled DNA fragment in binding buffer (6 mm Tris/HCl, 6 mm MgCl 2 , 150 mm NaCl, 1 mm DTT, pH 7.9) for 10 min at room temperature. Glycerol was then added to a final volume of 10% and the mixture was then analyzed by gel electrophoresis in a native 4% polyacrylamide gel in 0.5× TBE at 4°C for 1.5 h. Bands were visualized by autoradiography of the dried gels. For competition experiments different unlabeled nucleic acids were added to the reaction mix.
Results
MLL-ENL is a promoter and cell line specific transactivator
The transcriptional effects of MLL-ENL were analyzed by cotransfection of increasing quantities of a MLL-ENL expression plasmid together with constant amounts of luciferase reporter constructs. The full length murine Hoxa7 promoter as defined by Püschel et al, 22 and a human ␣ 2 -macroglobulin minimal promoter from position −48 to +1 (␣ 2 -48) 25 served as cellular target promoters. Additionally the CMV promoter-enhancer combination (CMV), a SV40 minimal promoter without enhancer (SV40p) and the Herpes simplex thymidine kinase promoter up to position −169 (TK-169) were tested as examples of viral promoters. The initial experiments were conducted in the B cell precursor cell line REH and the MLL-ENL cDNA and all derivatives thereof were expressed under control of the retroviral long terminal repeat (LTR) in the vec-tor pMSCV. 26 To exclude possible autofeedback artefacts the same LTR was also tested as a luciferase reporter construct (LTR). The cotransfection of increasing amounts of the MLL-ENL expression construct caused a corresponding strong increase in the luciferase activity for three of the tested promoters. With Hoxa7, SV40p and TK-169 the luciferase activities were up to 30-fold higher in cells co-expressing MLL-ENL than in cells without this fusion protein (Figure 1 ). In contrast, the CMV, the ␣ 2 -48, and the LTR promoters did not show any significant activity change in response to MLL−ENL. The basic strength of the individual promoter constructs covered three orders of magnitude with CMVϾϾSV40pϾLTRϾHoxa7ෂTK -169ෂ␣ 2 relevant physiological target within the test set that could be activated by MLL-ENL all further experiments were solely conducted with this reporter construct.
To investigate the cell line specificity of the MLL-ENL transactivation capability the human cell lines HL-60 (promyelocytic), U937 (monoblastic), Jurkat (T cells), Namalwa (B cell), Raji (B cell), K562 (erythroleukemic) and the mouse cell lines 32D (myeloid) and 3T3 (fibroblast) were cotransfected with 1 g of MLL-ENL expression plasmid and 1 g reporter construct. Empty expression vector served as a control to determine the basal promoter activity. The observed transactivation effect was cell line specific with no apparent pattern in the cell type that was responsive to MLL-ENL. The transactivation was functional in mouse, as well as human cells and it was strongest in the human REH and the mouse 32D cells. A weaker response was seen in human Jurkat, HL-60 and U937 cells, as well as in mouse NIH3T3 fibroblasts. The reporter output was not significantly changed by MLL-ENL in the human Namalwa, K562 and Raji lines ( Table 1) .
The transactivation capability of MLL-ENL requires the MT region of MLL, and the C-terminus of ENL and works optimal with the full length Hoxa7 promoter
Next, a structure function analysis was conducted to elucidate the importance of the known domains within MLL-ENL for the overall transactivation capability. For this purpose four mutants targeting either the AT-hooks, the MT homology domain, the ENL N-terminus or the ENL C-terminus, respectively, were cotransfected together with the Hoxa7 reporter into REH cells. Additionally the contribution of the MLL moiety alone without any fusion partner was tested. The appropriate expression and correct nuclear import of each mutant protein was verified by Western blot assays of nuclear extracts from 293 cells transfected with the individual constructs. All proteins expressed from the mutant plasmids could be detected in the nuclear fraction and showed the expected apparent molecular weight (Figure 2, insets) . For the data interpretation the luciferase activity resulting from the cotransfection of full length MLL-ENL was set to 100% and the residual activities of the mutant proteins were normalized relative to this value (Figure 2) . While a deletion of the AThook motif did not diminish the transactivation potential of MLL-ENL in our test system (mutant-AT hooks), a loss of the MT region extinguished it completely (mutant-MT motif). The mutant analysis also revealed that the transactivation potential was contingent on the fusion of MLL with ENL. The contribution of ENL was mainly due to its C-terminus. An N-terminal deletion of 426 out of 555 amino acids in ENL that are fused to MLL lead only to a moderate decrease in the overall transactivation capability of the resulting mutant (-ENL Nterm). However, a deletion of the very C-terminal 15 amino acids of ENL caused a substantial reduction in the transactivation capacity (-ENL C-term) with only approximately 20% of the original activity remaining. A further truncation of the fusion portion leaving only MLL sequences abolished almost all activation potential. An expression of ENL by itself, however, did not procure any detectable luciferase activity above background (not shown). Thus it is the cooperation of MLL and ENL that produces a novel transactivation activity.
A deletion analysis of the Hoxa7 promoter was conducted to define potential MLL-ENL response elements. A 480 bp enhancer and a transcription start site are the only regulatory elements that have been so far experimentally identified within the 2.8 kb Hoxa7 promoter sequence. 23, 24 Additionally a multitude of potential transcription factor sites has been predicted downstream of the transcription start by computer programs. 29 Several truncated promoter mutants were inserted into the luciferase reporter pGL-3 basic and cotransfected into REH cells together with either empty expression vector or the MLL-ENL expression construct (Figure 2b) . The entire 2.8 kb sequence was necessary to produce a full transactivation effect as judged by the luciferase assays. The deletion of 1.1 kb sequence located upstream of the transcription start site (mut1) reduced the achievable transactivation to approximately one third of the maximum value. This residual transactivation level remained approximately constant (mut2, mut3) upon further deletions down to 22 bp 5Ј of the transcription start site. A reporter construct without any Hoxa7 promoter sequences did not produce any detectable luciferase levels above background ruling out the presence of cryptic promoter elements in the vector backbone.
The fusion of ENL with MLL combines a protein interaction surface with a DNA binding domain
To investigate the mechanism of transcriptional transactivation by MLL-ENL squelching experiments were performed. In this type of experiment a mutant, non-functional transactivator molecule is co-expressed in excess together with the wild-type activator. If this mutant engages in a non-productive interaction with a factor that is necessary for the transactivation ability of the wild-type protein and this factor is present in limiting concentrations, the mutant will suppress the transactivation effect. Here, the MT deletion mutant and the Cterminal ENL truncation were tested in these types of experiment. Increasing amounts of either mutant were transfected into REH cells together with wild-type MLL-ENL. As a control the effect of the mutant itself on the reporter activity was monitored (Figure 3) . The luciferase activity obtained with full length MLL-ENL was set to 100% and all other activities were normalized to this value. As the results show, an excess of the ENL C-terminal deletion mutant has a synergistic effect on the Hoxa7 promoter activity (Figure 3, left panel) . However, in the controls this mutant still contained a slight but significant transactivation ability that appeared to work cooperatively with full-length MLL-ENL. This mutant did not interfere detectably with a component critical for the activation effect. In contrast, the expression of a mutant with intact ENL but impaired MT domain produced a significant decrease of the observed luciferase activities when co-transfected with wildtype MLL-ENL. This suggested a disturbance of a vital component of the transactivation machinery ( Figure 3, right panel) .
The amino acid homology data and preliminary experiments 16 assigned a potential DNA binding function to the MT domain. To analyze this activity and to identify possible binding sites for this domain within the Hoxa7 promoter sequence, gel mobility shift analyses were conducted. The cDNA sequence coding for the 96 amino acids of the complete MT motif was cloned as a fusion with GST into the vector pGEX-3X. The resulting protein was expressed in E. coli and purified by glutathione affinity chromatography. Potential binding sites for known transcription factors, as well as unusual sequence motifs that might be binding sites for unknown factors had been predicted by computer analysis within the Hoxa7 pro- 
Figure 3
Analysis of the MLL-ENL transactivation capability by squelching experiments. REH cells were triple-transfected with 0.5 g of Hoxa7-reporter plasmid, 0.5 g MLL-ENL expression construct and increasing amounts of plasmids expressing either an ENL C-terminal mutant or a MT-motif deletion mutant (dark bars). As a control the effects of the mutant expression in absence of full length MLL-ENL were determined (light bars). The promoter activity without cotransfection of a mutant was set to 100 and all other values are expressed as percentage of this reference. The chart represents the mean and standard deviation of three experiments.
moter sequence downstream of the transcription initiation site. 29 Therefore the gel mobility shift analysis was performed with a set of DNA fragments covering the promoter completely from the BamHI site to the SacI site (Figure 4) . The fragments were end-labeled with ␥-32 P ATP and T4 polynucle-
Figure 4
Complex formation of purified GST-MT protein with DNA. GST-MT protein was allowed to bind to 10 000 c.p.m. of ␥ 32 P-labeled Hoxa7 promoter fragments in the indicated amounts and was subsequently subjected to electrophoresis in a 4% native polyacrylamide gel. Bands were visualized by autoradiography. The location within the Hoxa7 promoter and the size of the tested fragments are graphically shown (filled box: enhancer; arrow; transcription start point) and additionally indicated below the respective lanes. The position of the unbound DNA fragments is labeled 'free'. otide kinase, incubated with increasing amounts of purified GST-MT protein and subjected to native polyacrylamide gel electrophoresis. The results showed that the GST-MT protein was capable of forming complexes with each of the fragments. Longer fragments displayed multiple retarded complexes while shorter fragments showed only one shifted band. The individual fragments had no elaborate sequence homology amongst each other and did not contain any easily visible unique potential recognition sequence for the MT domain. Also there was no discernible CpG island present. The in vitro DNA binding capability of isolated GST-MT protein, devoid of any potential cooperation with other proteins, is either of a general DNA-binding nature or recognized a short sequence motif that is present in every DNA with sufficient length. This conclusion was further supported by the observation that the complex formation could be competed by unrelated unlabeled DNA (pBluescript, salmon sperm) that was added to the reaction mixture (not shown).
Discussion
In the study reported here we demonstrate a possible biological function for the complete MLL-ENL fusion protein. The combination of MLL with ENL creates a novel powerful transactivating molecule that specifically enhanced the transcription from several authentic viral and cellular promoters. In the chimeric protein the MT repressor activity is overcome by the fusion with ENL and this combination results in an overall transactivation effect. Interestingly this transactivation capability worked for several unrelated promoters whereas others remained unaffected. There is no obvious common sequence or special property that would distinguish the promoters that were susceptible to transactivation by MLL-ENL from those that were unresponsive. From the results obtained it seems possible that MLL-ENL conveys the activation effect through a more common transcription-related factor that is not a ubiquitous member of the basal transcriptional machinery but that is still involved in the activation of several non-homologous promoters. Besides promoter specificity the transactivation ability of MLL-ENL also was cell line specific. Similar results have been obtained using the isolated transactivation region of FEL, another MLL fusion partner. When fused to a GAL4 DNA binding domain FEL was active on GAL4 sequence-containing templates only in certain cell lines. 30 In contrast to MLL-ENL, however, the GAL4-FEL fusion was inactive in the B cell precursor cell line REH. These specificity differences are of potential interest because the nature of the fusion partner tends to specify the lineage of the resulting leukemia. For example, MLL-FEL is found exclusively in ALL, while MLL-ENL can be detected in lymphoid as well as myeloid leukemias. 31 A lineage dependent activity of the individual MLL fusion partners might be a possible explanation for these observations. According to the results of the mutational analysis the transactivation capability of MLL-ENL is due to a gain-of-function mechanism. It is crucially dependent on a cooperation between the MT homology domain in MLL and mainly the C-terminus of ENL. These two domains and the AT-hooks have been previously defined in bone marrow transformation assays as important determinants also for the oncogenic capacity of the fusion protein. 16 However, the AT-hook motif is dispensable for the transactivation activity of the molecule. This is likely to be a limitation of the transient transcription assay. In transient transfections the target promoter is present in an extrachromosomal state. In a cellular transformation assay the target genes are embedded in the natural chromatin environment. The AT-hooks, however, have been connected with the recognition of chromatin structure and it has been shown in in vitro experiments that a purified AThook domain binds to DNA with an altered structure, like intrinsically bent or cruciform DNA. These special DNA structures are characteristic for scaffold attachment regions (SAR) in chromatin. 32 The AT-hooks may therefore be dispensable for the transcriptional activation of an extrachromosomal promoter. The squelching experiments suggested that the contact to the transcriptional machinery is established through the interaction of ENL with a factor that is in limiting supply. A surplus of a MT-domain deletion mutant might engage in an unproductive interaction with this ENL binding partner and therefore inhibit the activity of the wild-type MLL-ENL. The recruitment of a necessary partner protein might also be the basis for the cell line specificity. Interestingly the ENL C-terminus shows a weak homology to the yeast protein ANC-1 and ANC-1 is involved in three separate complexes all related to transcription: the SWI/SNF chromatin remodeling complex, the TFIID and the TFIIF transcription complexes. 33, 34 Experiments are currently under way to identify potential ENL binding partners and to clarify the relation between ENL and basal transcription. The MT domain on the other hand is most probably necessary to tether the MLL-ENL molecule to DNA. Isolated and purified MT domain protein did form distinct retarded complexes in vitro with any DNA template tested and this interaction was only dependent on the length of the fragments. It is not yet known if this domain binds to DNA without sequence specificity or if it recognizes short sequences that occur randomly in any piece of DNA of sufficient length. Both properties would explain the gel retardation results and examples are known for both binding modes. Many homeobox genes for instance recognize in vitro only the short sequence ATTA and it has been demonstrated for Eve and Ftz in Drosophila that they bind even in vivo with similar specificity to DNA sites throughout the length of the majority of genes. 35 The HMG (high motility group) proteins on the other hand truly bind without sequence specificity to DNA and still are necessary for the optimal enhancer dependent transcription of specific genes. 36, 37 For the MT-motif in the eukaryotic methyltransferases it has been speculated that it allows the enzyme to recognize DNA by structure rather than by sequence and that it binds the altered shape of methylated DNA. 38 The MT motif also occurs twice in a protein subunit of the MeCP1 repressor complex that functions in repressing methylated promoter sequences. 39 In this regard it is interesting to note that also for the polycomb genes in Drosophila no in vitro DNA sequence specificity could be detected. Still, these proteins bind distinct target promoters as demonstrated by in situ immunohistochemistry on polytene chromosomes. Moreover, similar to the transactivation of the Hoxa7 promoter by MLL-ENL, the repression of target promoters by polycomb proteins seems to rely on extended response elements with longer promoters showing a more profound response to polycomb repression than truncated partial promoters (for a comprehensive review see Ref. 40) . The target specificity in vivo of MLL and MLL-ENL is very likely determined by additional protein-protein interactions within the N-terminal portion that is conserved in the fusion. Consequently, MLL and MLL-ENL are co-localized in the same specific subnuclear pattern. 41 The activation potential of MLL-ENL for the Hoxa7 promoter emphasizes the Hox homeobox genes as prime targets for the leukemogenesis through MLL-ENL. A precisely executed program of spatially and temporarily restricted Hox gene expression has an important role during hematopoiesis. The expression of various Hox genes was found to be highest in undifferentiated CD34
+ hematopoietic progenitor cells and was down-regulated in a meticulously regulated program during differentiation to mature blood cells. 42, 43 This decrease in Hox expression was accompanied by an increase in the expression of mammalian polycomb group repressor proteins suggesting a conserved mechanism of Hox regulation between fruit flies and mammals. 44 In addition, an ectopic expression of various Hox genes in mouse bone marrow by retroviral infection has been shown to elicit highly lineage-specific effects on the proliferative and self-renewal abilities of stem cells and committed precursors (review in Ref. 43) . Further studies of the Hox gene regulation by MLL fusion proteins will clarify if the MLL-Hox connection is indeed a causative agent for leukemogenesis.
